12:00 AM
 | 
Mar 06, 2000
 |  BC Week In Review  |  Company News  |  Deals

Synaptic, Merck deal

MRK relinquished its 1993 exclusive license to SNAP's alpha-adrenergic technology and related patents. SNAP will make the technology available for licensing to others....

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >